{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:44:40Z","timestamp":1776685480329,"version":"3.51.2"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Kohlmeier\u2013Degos disease is a potentially severe multiorgan thrombotic vascular injury syndrome with characteristic cutaneous lesions characterized by depressed porcelain white plaques with telangiectatic rims. This occlusive vasculopathy involves the microvasculature but also extends to affect arterioles and small arteries where a peculiar intravascular and intimal fibrosing reaction occurs. We discovered in earlier studies that complement pathway activation and enhanced type I interferon signaling are held to be a critical impetus for the endothelial cell injury. Significant upregulation of type I interferon signaling is also responsible for the neointimal expansion and fibrosis. We had the opportunity of examining before and after treatment biopsies in a pediatric patient receiving the 3-drug protocol for the treatment of Kohlmeier\u2013Degos disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The patient was a 13-year-old girl who presented with a few months history of depressed white macular skin lesions and abdominal pain. A laparotomy revealed multiple serosal porcelain plaques and evidence of acute severe intestinal ischemia. The patient's pretreatment skin and intestinal resection samples showed a striking pauci-inflammatory microangiopathy associated with endothelial cell necrosis and microvascular thrombosis and arteriolar and arterial neointimal hyperplasia with intimal fibrosis, extensive vascular C5b-9 deposition and enhanced type I interferon signaling in the skin and intestine. Extravascular fibrosis with a loss in the expression of CD34 amid fibroblasts was observed. A diagnosis was made of Kohlmeier\u2013Degos disease. The post-treatment biopsies of the skin and intestine demonstrated complete abrogation of both endothelial cell injury and intravascular fibrin thrombi. There was no evidence of neointimal fibrosis. The CD34 negative procollagen scleroderma phenotype was not observed in fibroblasts. A discernible but less intense type I interferon signal was present while the C5b-9 studies were negative in the post-treatment skin biopsy. The intestinal resection specimen obtained several months later had a negative interferon signature. Fibrous intravascular occlusion was limited to rare vessels in the intestinal resection specimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The cutaneous and extracutaneous lesions of Kohlmeier\u2013Degos disease are potentially reversible. The combination of therapeutic complement inhibition, downregulation of type I interferon expression, and the promotion of vascular patency and reduced platelet activation through prostacyclin administration define the cornerstone of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dad.0000000000003193","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:00:54Z","timestamp":1767211254000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Evolution in the Cutaneous and Gastrointestinal Pathology of Pediatric Kohlmeier\u2013Degos Disease Under Combined Modality Therapy"],"prefix":"10.1097","volume":"48","author":[{"given":"Cynthia M.","family":"Magro","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Kessler","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Helen Devos Childrens Hospital, Grand, Rapids, MI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Foster","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology, Helen Devos Childrens Hospital, Grand Rapids, MI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Albany Medical College, Albany, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01828450","article-title":"Multiple skin necrosis in thrombangiitis obliterans","volume":"181","author":"K\u00f6hlmeier","year":"1941","journal-title":"Archiv f\u00fcr Dermatologie und Syphilis"},{"key":"R2-20260420","first-page":"148","article-title":"Dermatite papulosquameuse atrophiante","volume":"49","author":"Degos","year":"1942","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"R3-20260420","first-page":"414","article-title":"Diabetes mellitus and Degos disease","volume":"109","author":"Fernandez-Flores","year":"2008","journal-title":"Bratisl Lek Listy"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2340\/00015555-0068","article-title":"A fatal case of malignant atrophic papulosis (Degos' disease) in a man with factor V Leinden mutation and lupus anticoagulant","volume":"86","author":"Hohwy","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ijd.13629","article-title":"Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis","volume":"56","author":"Vinay","year":"2017","journal-title":"Int J Dermatol"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5021\/ad.2017.29.2.215","article-title":"Degos-like lesions associated with systemic lupus erythematosus","volume":"29","author":"Jang","year":"2017","journal-title":"Ann Dermatol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0378-6323.77477","article-title":"Degos disease-like presentation in systemic lupus erythematosus","volume":"77","author":"Riyaz","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2310\/7750.2011.10035","article-title":"Degos disease with dermatomyositis-like phenomenon: a diagnostic dilemma and a therapeutic challenge","volume":"15","author":"Gupta","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"R9-20260420","first-page":"101","article-title":"Lesions resembling malignant atrophic papulosis in a patient with progressive systemic sclerosis","volume":"75","author":"Liu","year":"2005","journal-title":"Cutis"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/DAD.0000000000002765","article-title":"Tumor necrosis factor ALPHA inhibitor associated K\u00f6hlmeier-Degos disease as a novel iatrogenic paradigm that underscores excessive type I interferon in its pathogenesis","volume":"46","author":"Magro","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-8-10","article-title":"Malignant atrophic papulosis (K\u00f6hlmeier-Degos disease)-A review","volume":"8","author":"Theodoridis","year":"2013","journal-title":"Orphanet J rare Dis"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2230.2007.02497.x","article-title":"Malignant atrophic papulosis","volume":"32","author":"Scheinfeld","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-\u03b1\u2013mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1750-1172-8-185","article-title":"The effects of Eculizumab on the pathology of malignant atrophic papulosis","volume":"8","author":"Magro","year":"2013","journal-title":"Orphanet J rare Dis"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJM196701262760402","article-title":"Progressive arterial occlusive disease (K\u00f6hlmeier-Degos). A frequently fatal cutaneosystemic disorder","volume":"276","author":"Strole","year":"1967","journal-title":"N Engl J Med"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"151943","DOI":"10.1016\/j.anndiagpath.2022.151943","article-title":"Exploring the pathophysiologic basis of constrictive pericarditis of Kohlmeier Degos disease: a case series and review of the literature","volume":"59","author":"Magro","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-8-52","article-title":"Effective treatment of malignant atrophic papulosis (K\u00f6hlmeier-Degos disease) with treprostinil\u2013early experience","volume":"8","author":"Shapiro","year":"2013","journal-title":"Orphanet J rare Dis"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clindermatol.2024.09.020","article-title":"The utility of the normal thin section skin biopsy in the assessment of systemic\/extracutaneous disease and small fiber neuropathy","volume":"42","author":"Magro","year":"2024","journal-title":"Clin Dermatol"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis","volume":"37","author":"Magro","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/bloodadvances.2018020644","article-title":"Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b\/2 studies","volume":"2","author":"R\u00f6th","year":"2018","journal-title":"Blood Adv"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/19420862.2015.1007810","article-title":"Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-\u03b1 receptor 1 antibody","volume":"7","author":"Peng","year":"2015","journal-title":"MAbs"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/bjd\/ljaf106","article-title":"Rescue therapy in malignant atrophic papulosis: a new era of promising treatments targeting interferon and complement pathways","volume":"193","author":"El Maamar","year":"2025","journal-title":"Br J Dermatol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"e20190459","DOI":"10.1084\/jem.20190459","article-title":"Type-I interferons in atherosclerosis","volume":"217","author":"Chen","year":"2020","journal-title":"J Exp Med"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000084406","article-title":"Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue","volume":"42","author":"Jabs","year":"2005","journal-title":"J Vasc Res"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"978262","DOI":"10.3389\/fimmu.2022.978262","article-title":"Jmjd3\/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis","volume":"13","author":"Liang","year":"2022","journal-title":"Front Immunol"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"581385","DOI":"10.3389\/fimmu.2020.581385","article-title":"IFN-I mediates dysfunction of endothelial progenitor cells in atherosclerosis of systemic lupus erythematosus","volume":"11","author":"Ding","year":"2020","journal-title":"Front Immunol"},{"key":"R27-20260420","first-page":"281","article-title":"Reduction of acute pulmonary hypertension by prostacyclin","volume":"22","author":"Borchert","year":"1980","journal-title":"Cor Vasa"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","article-title":"Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist","volume":"84","author":"Whittle","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"25","key":"R29-20260420","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1161\/01.CIR.102.25.3130","article-title":"Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells","volume":"102","author":"Wharton","year":"2000","journal-title":"Circulation"},{"issue":"11","key":"R30-20260420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205195","article-title":"Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells","volume":"13","author":"Lambers","year":"2018","journal-title":"PLoS ONE"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"e0205195","DOI":"10.1371\/journal.pone.0205195","article-title":"Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells","volume":"13","author":"Lambers","year":"2018","journal-title":"PLoS One"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2007.06.135","article-title":"IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues","volume":"360","author":"Falcetti","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"R33-20260420","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3324\/haematol.2020.255612","article-title":"Human platelets are a source of collagen I","volume":"106","author":"Kyselova","year":"2020","journal-title":"Haematologica"},{"key":"R34-20260420","first-page":"1017","article-title":"Eculizumab (Alexion)","volume":"3","author":"Kaplan","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1474-4422(22)00167-3","article-title":"Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement","volume":"21","author":"Becker","year":"2022","journal-title":"Lancet Neurol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:01:12Z","timestamp":1776682872000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003193","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}